Divi's Laboratories Ltd
NSE:DIVISLAB

Watchlist Manager
Divi's Laboratories Ltd Logo
Divi's Laboratories Ltd
NSE:DIVISLAB
Watchlist
Price: 6 632 INR 1.34% Market Closed
Market Cap: 1.8T INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
-27%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

DIVISLAB Price Targets Summary
Divi's Laboratories Ltd

Wall Street analysts forecast DIVISLAB stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DIVISLAB is 6 277.77 INR with a low forecast of 4 138.98 INR and a high forecast of 8 137.5 INR.

DIVISLAB Lowest Forecast
Wall Street Target
4 138.98 INR
38% Downside
DIVISLAB Average Forecast
Wall Street Target
6 277.77 INR
5% Downside
DIVISLAB Highest Forecast
Wall Street Target
8 137.5 INR
23% Upside
Lowest
Price Target
4 138.98 INR
38% Downside
Average
Price Target
6 277.77 INR
5% Downside
Highest
Price Target
8 137.5 INR
23% Upside
Divi's Laboratories Ltd Competitors:
Price Targets
SAILIFE
Sai Life Sciences Ltd
11% Upside
WST
West Pharmaceutical Services Inc
26% Upside
TKNO
Alpha Teknova Inc
89% Upside
Q
QSI
Quantum-Si Inc
66% Upside
SAILIFE
Sai Life Sciences Ltd
11% Upside
WST
West Pharmaceutical Services Inc
26% Upside
TKNO
Alpha Teknova Inc
89% Upside
Q
QSI
Quantum-Si Inc
66% Upside
CHEMM
Chemometec A/S
17% Upside
TECN
Tecan Group AG
29% Upside
M
300463
Maccura Biotechnology Co Ltd
14% Upside
DHR
Danaher Corp
27% Upside

Revenue
Forecast

Revenue Estimate
Divi's Laboratories Ltd

For the last 8 years the compound annual growth rate for Divi's Laboratories Ltd's revenue is 11%. The projected CAGR for the next 3 years is 19%.

11%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Divi's Laboratories Ltd

For the last 8 years the compound annual growth rate for Divi's Laboratories Ltd's operating income is 8%. The projected CAGR for the next 3 years is 25%.

8%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Divi's Laboratories Ltd

For the last 8 years the compound annual growth rate for Divi's Laboratories Ltd's net income is 10%. The projected CAGR for the next 3 years is 23%.

10%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

See Also

Summary
DIVISLAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
DIVISLAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DIVISLAB stock valuation using valuation multiples.
Wall Street Estimates
DIVISLAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DIVISLAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DIVISLAB's stock price target?
Price Target
6 277.77 INR

According to Wall Street analysts, the average 1-year price target for DIVISLAB is 6 277.77 INR with a low forecast of 4 138.98 INR and a high forecast of 8 137.5 INR.

What is Divi's Laboratories Ltd's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Divi's Laboratories Ltd's revenue is 11%. The projected CAGR for the next 3 years is 19%.

What is Divi's Laboratories Ltd's Operating Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Divi's Laboratories Ltd's operating income is 8%. The projected CAGR for the next 3 years is 25%.

What is Divi's Laboratories Ltd's Net Income forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for Divi's Laboratories Ltd's net income is 10%. The projected CAGR for the next 3 years is 23%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 260,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.